Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Saavedra

Showing results (151-160 of 209) with videos related to

Pageof 21
Sort By:
The Biochemical Journal|May 13, 1998
Reactivation of triosephosphate isomerase from three trypanosomatids and human: effect of suraminX G Gao, G Garza-Ramos, E Saavedra-Lira, et al.
ACS Medicinal Chemistry Letters|January 8, 2011
The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of ProlineSam Y Hong, Gregory L Borchert, Anna E Maciag, et al.
Molecular Pharmacology|November 17, 2005
A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteinsDanyelle M Townsend, Victoria J Findlay, Farit Fazilev, et al.
Nitric Oxide : Biology and Chemistry|December 4, 2001
Protection of human keratinocyte mtDNA by low-level nitric oxideI Shokolenko, T M Oberyszyn, S M D'Ambrosio, et al.
Journal of Vascular Surgery|March 13, 2010
Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injuryNick D Tsihlis, Jozef Murar, Muneera R Kapadia, et al.
Bioorganic & Medicinal Chemistry|April 7, 2012
Structural modifications modulate stability of glutathione-activated arylated diazeniumdiolate prodrugsRahul S Nandurdikar, Anna E Maciag, Ryan J Holland, et al.
Nitric Oxide : Biology and Chemistry|February 2, 2013
Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRIClaudia Weidensteiner, Wilfried Reichardt, Paul J Shami, et al.
Molecular Pharmacology|April 23, 2004
Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrugVictoria J Findlay, Danyelle M Townsend, Joseph E Saavedra, et al.
Nitric Oxide : Biology and Chemistry|January 27, 1998
Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemiaJ Ou, T M Carlos, S C Watkins, et al.
Molecular Cancer Therapeutics|June 24, 2004
Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulationJie Liu, Chengxiu Li, Wei Qu, et al.
Pageof 21

Showing results (151-160 of 209) with videos related to

Sort By:
Pageof 21
The Biochemical Journal|May 13, 1998
Reactivation of triosephosphate isomerase from three trypanosomatids and human: effect of suraminX G Gao, G Garza-Ramos, E Saavedra-Lira, et al.
ACS Medicinal Chemistry Letters|January 8, 2011
The Nitric Oxide Prodrug V-PROLI/NO Inhibits Cellular Uptake of ProlineSam Y Hong, Gregory L Borchert, Anna E Maciag, et al.
Molecular Pharmacology|November 17, 2005
A glutathione S-transferase pi-activated prodrug causes kinase activation concurrent with S-glutathionylation of proteinsDanyelle M Townsend, Victoria J Findlay, Farit Fazilev, et al.
Nitric Oxide : Biology and Chemistry|December 4, 2001
Protection of human keratinocyte mtDNA by low-level nitric oxideI Shokolenko, T M Oberyszyn, S M D'Ambrosio, et al.
Journal of Vascular Surgery|March 13, 2010
Isopropylamine NONOate (IPA/NO) moderates neointimal hyperplasia following vascular injuryNick D Tsihlis, Jozef Murar, Muneera R Kapadia, et al.
Bioorganic & Medicinal Chemistry|April 7, 2012
Structural modifications modulate stability of glutathione-activated arylated diazeniumdiolate prodrugsRahul S Nandurdikar, Anna E Maciag, Ryan J Holland, et al.
Nitric Oxide : Biology and Chemistry|February 2, 2013
Effects of the nitric oxide donor JS-K on the blood-tumor barrier and on orthotopic U87 rat gliomas assessed by MRIClaudia Weidensteiner, Wilfried Reichardt, Paul J Shami, et al.
Molecular Pharmacology|April 23, 2004
Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrugVictoria J Findlay, Danyelle M Townsend, Joseph E Saavedra, et al.
Nitric Oxide : Biology and Chemistry|January 27, 1998
Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemiaJ Ou, T M Carlos, S C Watkins, et al.
Molecular Cancer Therapeutics|June 24, 2004
Nitric oxide prodrugs and metallochemotherapeutics: JS-K and CB-3-100 enhance arsenic and cisplatin cytolethality by increasing cellular accumulationJie Liu, Chengxiu Li, Wei Qu, et al.
Pageof 21